跳至主要内容
临床试验/ITMCTR2200006595
ITMCTR2200006595招募中4 期

Clinical effect of promoting blood circulation and removing stasis on improving cognitive function of patients with hypertension arteriosclerosis and cerebral small vessel disease

The First Clinical Medical College of Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
50 至 80(—)
性别
All

入选标准

  • ? Outpatient or inpatient patients aged 50-80 years old and elderly residents in the community, regardless of gender, education level =6 years;
  • ? Meet the diagnostic criteria of Western medicine and Chinese medicine;
  • ? no history and signs of stroke;
  • ? Willing to be randomly assigned to the test group and the control group;
  • ? Volunteer to participate in the experiment and sign the informed consent.

排除标准

  • ? Patients with severe heart, liver and kidney insufficiency;
  • ? Patients with other mental and nervous system diseases and malignant tumors;
  • ? Participants who had participated in other drug trials within three months before enrollment;
  • ? Poor compliance or life-threatening can not complete the course of treatment;
  • ? Use of other cognitive-improving drugs such as ChEIs or other psychotropic drugs within the last three months.

研究者

发起方
The First Clinical Medical College of Beijing University of Chinese Medicine

相似试验